Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancer
- PMID: 25383449
- DOI: 10.3109/0284186X.2014.969846
Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancer
Abstract
Background: Docetaxel is a highly effective treatment of a wide range of malignancies but is often associated with peripheral neuropathy. The genetic variability of genes involved in the transportation or metabolism of docetaxel may be responsible for the variation in docetaxel-induced peripheral neuropathy (DIPN). The main purpose of this study was to investigate the impact of genetic variants in GSTP1 and ABCB1 on DIPN.
Material and methods: DNA was extracted from whole blood from 150 patients with early-stage breast cancer who had received adjuvant docetaxel from February 2011 to May 2012. Two polymorphisms in GSTP1 and three in ABCB1 were selected for the primary analysis, and a host of other candidate genes was explored and compared between 75 patients with clinician-reported DIPN grade ≥ 2 and 75 patients without DIPN.
Results: Patients with the genetic variants GSTP1 rs1138272 C/T or T/T (114Ala/114Val or 114Val/114Val) genotype had an adjusted odds ratio of 3.82; 95% confidence interval 1.34-11.09 of developing DIPN. This result was confirmed in both analysis of cumulated docetaxel dose and haplotype analysis. None of the explorative genes investigated were significantly correlated with DIPN. Patients with a BMI ≥ 30 were five-fold more likely to have DIPN than patients with BMI < 25.
Conclusion: We found that GSTP1 Ala114Val polymorphism is associated with occurrence of DIPN. This supports the theory that oxidative stress is involved in DIPN pathophysiology. If confirmed, this may be helpful in the risk assessment of DIPN and perhaps help to achieve better management of neurotoxicity.
Similar articles
-
Docetaxel-induced severe neuropathy, a case of breast cancer with GTSP1 polymorphism.J Oncol Pharm Pract. 2025 Mar;31(2):325-328. doi: 10.1177/10781552241279831. Epub 2024 Aug 28. J Oncol Pharm Pract. 2025. PMID: 39195359
-
Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.Ann Oncol. 2009 Apr;20(4):736-40. doi: 10.1093/annonc/mdn698. Epub 2009 Feb 17. Ann Oncol. 2009. PMID: 19223573
-
Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer.Breast Cancer Res Treat. 2013 Nov;142(1):109-18. doi: 10.1007/s10549-013-2728-2. Epub 2013 Oct 17. Breast Cancer Res Treat. 2013. PMID: 24132874
-
Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis.Clin Transl Sci. 2022 Oct;15(10):2403-2436. doi: 10.1111/cts.13370. Epub 2022 Aug 17. Clin Transl Sci. 2022. PMID: 35892315 Free PMC article.
-
[Fatal acute interstitial lung disease associated with docetaxel administration: about a case and review of the literature].Pan Afr Med J. 2016 Jun 7;24:119. doi: 10.11604/pamj.2016.24.119.8902. eCollection 2016. Pan Afr Med J. 2016. PMID: 27642457 Free PMC article. Review. French.
Cited by
-
Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis.Support Care Cancer. 2021 Dec;29(12):7461-7469. doi: 10.1007/s00520-021-06321-7. Epub 2021 Jun 3. Support Care Cancer. 2021. PMID: 34085148 Free PMC article.
-
Bibliometric Analysis Reveals a 20-Year Research Trend for Chemotherapy-Induced Peripheral Neuropathy.Front Neurol. 2022 Feb 8;12:793663. doi: 10.3389/fneur.2021.793663. eCollection 2021. Front Neurol. 2022. PMID: 35211075 Free PMC article.
-
Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review.J Natl Cancer Inst. 2018 Feb 1;110(2):djx140. doi: 10.1093/jnci/djx140. J Natl Cancer Inst. 2018. PMID: 28954296 Free PMC article.
-
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy.Front Pharmacol. 2020 Apr 15;11:445. doi: 10.3389/fphar.2020.00445. eCollection 2020. Front Pharmacol. 2020. PMID: 32351390 Free PMC article. Review.
-
The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment.Pharmgenomics Pers Med. 2016 Apr 27;9:47-58. doi: 10.2147/PGPM.S86672. eCollection 2016. Pharmgenomics Pers Med. 2016. PMID: 27175090 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous